Keratosis pilaris is a harmless yet common skin condition that creates small, rough bumps on the skin, often compared to gooseflesh or chicken skin. While there is no definitive cure for this condition, a variety of treatment approaches—from simple moisturizers to prescription creams—can help improve the appearance and texture of affected skin, offering relief and boosting confidence for those who feel self-conscious about these persistent bumps.

Managing a Harmless but Frustrating Skin Condition

Keratosis pilaris, often called KP or “chicken skin,” affects millions of people worldwide, yet many who live with it don’t fully understand what causes those persistent bumps on their arms, thighs, or cheeks. The primary goal when addressing keratosis pilaris is not to cure it—since it cannot be cured or prevented—but rather to improve the skin’s appearance and texture, reduce dryness and irritation, and help individuals feel more comfortable in their own skin. Treatment approaches are highly individualized and depend on the severity of the condition, the patient’s age, the location of the bumps, and how much the condition affects their quality of life. Some people seek treatment for cosmetic reasons, while others simply want relief from the rough texture or occasional itchiness that accompanies the bumps.^[1][2]

Because keratosis pilaris is considered by many dermatologists to be a variation of normal skin rather than a disease that requires aggressive intervention, the decision to treat is entirely personal. Many patients, especially children and teenagers, experience the condition most prominently, and it often improves or disappears entirely by age 30. However, the bumpy texture and sometimes red or brown discoloration can cause embarrassment, particularly when wearing sleeveless clothing or shorts. Understanding that this is a common, benign condition—affecting an estimated 50 to 80 percent of adolescents and 40 percent of adults—can provide reassurance. But for those who wish to smooth their skin and reduce the visibility of bumps, there are both standard treatments approved by dermatologists and emerging therapies being explored in research settings.^[2][3]

Standard Treatment Approaches

The cornerstone of managing keratosis pilaris lies in consistent skin care that addresses the underlying problem: the buildup of keratin, a protein that normally protects the skin but, in KP, accumulates and plugs hair follicles. Standard treatments focus on loosening and removing this excess keratin, moisturizing the skin, and reducing inflammation when present. Most treatments are topical, meaning they are applied directly to the skin, and they work best when used regularly over weeks or months.^[10][16]

One of the most commonly recommended types of products are topical exfoliants, which help dissolve the keratin plugs and remove dead skin cells from the surface. These creams and lotions often contain alpha hydroxy acids (such as lactic acid or glycolic acid), salicylic acid, or urea. Alpha hydroxy acids work by breaking down the bonds between dead skin cells, allowing them to shed more easily and preventing the formation of new plugs. Lactic acid is particularly popular because it not only exfoliates but also helps the skin retain moisture. Urea serves a dual purpose: it softens the skin and helps loosen keratin. Salicylic acid, a beta hydroxy acid, penetrates into the pores and helps clear blockages from within the hair follicles.^[10][16]

These exfoliating products are available both over the counter and by prescription, depending on their strength. Over-the-counter formulations typically contain lower concentrations and can be used as part of a daily skincare routine. Prescription-strength versions are reserved for more stubborn cases and should be applied according to a healthcare provider’s guidance. However, patients should be aware that these acids can sometimes cause skin irritation, stinging, or redness, especially when first starting treatment or when applied too frequently. This is why they are generally not recommended for very young children, whose skin is more sensitive.^[10]

Another category of standard treatment involves topical retinoids, which are derivatives of vitamin A. Common prescription retinoids include tretinoin, tazarotene, and adapalene. These medications work by promoting cell turnover, which means they help the skin shed dead cells more quickly and prevent the plugging of hair follicles. By accelerating the natural renewal process of the skin, retinoids can gradually smooth out the rough texture associated with keratosis pilaris. However, retinoids can also be drying and irritating, particularly at the start of treatment. To minimize side effects, patients are often advised to use them in combination with a gentle moisturizer and to apply them only a few times per week at first, gradually increasing frequency as the skin adjusts. Pregnant or nursing women are typically advised to avoid retinoids or delay their use, as these medications can pose risks during pregnancy.^[10][15]

Moisturizers play an essential supporting role in the treatment of keratosis pilaris. Keeping the skin well-hydrated helps reduce the rough, dry texture and can prevent irritation that makes the bumps more noticeable. Many dermatologists recommend using thick, emollient-based moisturizers that contain ingredients like urea, lactic acid, or ceramides. These ingredients not only hydrate but also help restore the skin’s natural barrier function. Moisturizers should be applied at least once or twice daily, ideally right after bathing when the skin is still slightly damp, to lock in moisture. During the winter months, when the air is drier and symptoms often worsen, even more frequent moisturizing may be beneficial.^[2][16]

When keratosis pilaris is accompanied by redness or itching, short-term use of topical corticosteroids—such as hydrocortisone—can provide temporary relief. These anti-inflammatory creams help calm irritated skin and reduce the inflammatory response around the bumps. However, corticosteroids are not a long-term solution. They are typically used for only one to two weeks at a time, as prolonged use can lead to skin thinning and other side effects. Corticosteroids do not address the underlying keratin buildup, so they are best used in combination with exfoliants or retinoids.^[16][19]

Treatment duration for keratosis pilaris is often indefinite. Because the condition is chronic and has a tendency to return, most patients need to continue their skincare routine even after improvement is noticed. If treatment is stopped, the bumps typically reappear within weeks or months. This ongoing maintenance can feel discouraging, but consistency is key to keeping the skin smooth. It’s also important to have realistic expectations: even with diligent treatment, keratosis pilaris may not disappear completely, but its appearance can be significantly improved.^[10][19]

In addition to these at-home and prescription treatments, some patients with more persistent or cosmetically bothersome keratosis pilaris may benefit from procedural interventions. Laser therapies, such as pulsed dye laser or intense pulsed light (IPL), have been used to reduce the redness and inflammation associated with the condition. These treatments target the blood vessels around the hair follicles, diminishing the pink or red halo that often surrounds the bumps. Laser-assisted hair removal has also been explored as a way to reduce ingrown hairs that can accompany keratosis pilaris. While these procedures are generally safe, they are typically considered elective and may require multiple sessions to achieve noticeable results.^[15]

Treatment in Clinical Trials

While standard treatments for keratosis pilaris are well established and widely available, there is ongoing research into new and innovative approaches that may offer additional options for patients in the future. Clinical trials exploring novel therapies are relatively limited for keratosis pilaris compared to other skin conditions, largely because KP is considered benign and not life-threatening. However, researchers continue to investigate therapies that could more effectively address the underlying causes of the condition or provide longer-lasting relief.

One area of interest is the use of topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, which are commonly used to treat inflammatory skin conditions like eczema. These medications work by suppressing the immune response in the skin, which can reduce inflammation and irritation. Although not yet widely adopted as a standard treatment for keratosis pilaris, case reports and small studies have suggested that these agents may be beneficial in reducing redness and improving skin texture, particularly in patients who do not tolerate retinoids or corticosteroids well. Topical pimecrolimus, for example, has been reported to show success in individual cases, though larger clinical trials are needed to confirm its efficacy and safety for widespread use in keratosis pilaris.^[11]

Another investigational approach involves the use of diclofenac sodium gel, a nonsteroidal anti-inflammatory drug (NSAID) typically used for pain relief and inflammation. In a small report, diclofenac sodium 3% gel was successfully used in two patients with keratosis pilaris, suggesting that it may help reduce inflammation associated with the condition. This type of treatment is still in early stages of exploration and would require further study to determine whether it could become a recommended option.^[11]

In addition to topical therapies, some research has explored the potential role of systemic therapies, particularly for patients with severe or widespread keratosis pilaris. Oral retinoids, such as isotretinoin, acitretin, and alitretinoin, have been investigated primarily in the context of a related but distinct condition called keratosis follicularis (Darier disease), which shares some features with keratosis pilaris. These medications work by regulating skin cell production and reducing excessive keratin formation. Although oral retinoids have shown some promise in reducing hyperkeratosis and smoothing the skin, they are associated with significant side effects, including dry skin, liver toxicity, and birth defects if taken during pregnancy. As a result, they are rarely used for keratosis pilaris and are reserved for more serious conditions. However, the research conducted on these agents may inform future therapeutic strategies for KP.^[11]

Botulinum toxin injections have also been explored in a limited capacity. In one case, botulinum toxin type A was injected into skin affected by keratosis pilaris in the submammary (under the breast) area, resulting in significant relief from discomfort. The mechanism is thought to involve reducing sweating and friction in the area, which can worsen symptoms. This approach remains highly experimental and is not commonly used, but it highlights the creative ways researchers are thinking about managing this condition.^[11]

Emerging technologies, such as fractional carbon dioxide lasers and Nd:YAG lasers, are also being tested for their ability to improve the appearance of keratosis pilaris. These lasers work by creating controlled micro-injuries to the skin, which stimulate collagen production and promote skin remodeling. Early results suggest that these therapies may be effective in reducing both the texture and redness associated with KP, though they are typically offered in specialized dermatology clinics and may not be widely accessible. Clinical trials evaluating the long-term effectiveness and safety of these laser treatments are ongoing.^[3]

Another innovative area of research involves understanding the genetic and molecular basis of keratosis pilaris. Scientists have identified mutations in the filaggrin gene, which plays a critical role in maintaining the skin’s barrier function, as a potential contributing factor to KP. By studying these genetic pathways, researchers hope to develop targeted therapies that address the root cause of keratin accumulation rather than just treating the symptoms. While these discoveries are still in the early stages, they open the door to future treatments that could be more precise and effective.^[3][5]

It is important to note that most of these experimental treatments are not yet approved for routine use and are primarily being studied in research settings. Patients interested in participating in clinical trials for keratosis pilaris should consult with their dermatologist or search for trials through clinical trial registries. Trial participation allows patients to access cutting-edge therapies while contributing to the advancement of medical knowledge. However, it also involves some level of uncertainty, as these treatments are still being evaluated for safety and efficacy.

Most Common Treatment Methods

• Topical Exfoliants
  • Creams and lotions containing alpha hydroxy acids (lactic acid, glycolic acid) to break down keratin plugs and remove dead skin cells.
  • Salicylic acid formulations that penetrate into pores and clear blockages from within hair follicles.
  • Urea-based products that soften skin and help loosen excess keratin while retaining moisture.
• Topical Retinoids
  • Prescription tretinoin, tazarotene, and adapalene to promote cell turnover and prevent follicle plugging.
  • Used several times per week, often combined with moisturizers to reduce irritation and dryness.
• Moisturizers
  • Thick, emollient-based creams with urea, lactic acid, or ceramides to hydrate and restore skin barrier function.
  • Applied daily, especially after bathing, to lock in moisture and reduce rough texture.
• Topical Corticosteroids
  • Short-term use of hydrocortisone or other mild corticosteroids to reduce redness and itching.
  • Not recommended for long-term use due to risk of skin thinning.
• Laser and Light Therapies
  • Pulsed dye laser and intense pulsed light (IPL) to target redness and inflammation around bumps.
  • Fractional carbon dioxide lasers and Nd:YAG lasers to improve skin texture and stimulate collagen production.
  • Laser-assisted hair removal to reduce ingrown hairs associated with keratosis pilaris.
• Investigational Therapies
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) to reduce inflammation, especially in patients who cannot tolerate retinoids.
  • Diclofenac sodium gel as an anti-inflammatory agent, explored in small case reports.
  • Botulinum toxin injections for localized relief in specific body areas.